Background/Introduction: Glycogen is a polysaccharide found in animals as well as simpler organisms such as fungi. Glycogen is made up of glucose monomers and is considered the primary method of storing glucose in animals. In humans, glycogen is mainly synthesized in the liver (up to 6% of the total mass) and the muscles (approximately 2% of the total mass). Lesser amounts of glycogen are found in the kidneys, glial cells in the brain, and white blood cells. Glycogen also serves as an energy source in the uterus during pregnancy to supply glucose to the fetus. While fats in adipose tissue represent the main stored energy source, glycogen is the second most abundant stored energy source. Glycogen is similar in structure and function to starch, a polysaccharide composed of glucose monomers that also serves as energy storage in plants. Glycogen differs structurally from starch in that it is more extensively branched and compact than starch. Glycogen storage diseases (GSD) are a set of disorders caused by the disruption of glycogen metabolism. Disruption of the liver's ability to supply the rest of the body with glycogen can lead to low blood sugar levels. Additionally, if liver glycogen is not broken down effectively, this can lead to abnormal enlargement of the liver. Glycogen synthase mutations causing impaired protein function causes lower glycogen synthesis and causes the liver to be small. Finally, glycogen brancher deficiency can cause aberrant forms of glycogen to be stored in the liver ultimately causing a disorder of progressive liver dysfunction. Glycogen Assay Kit is a simple fluorometric assay that measures the amount of total glycogen present in biological samples in a 96-well microtiter plate format. Each kit provides sufficient reagents to perform up to 100 assays*, including blanks, glycogen standards, and unknown samples. Sample glycogen concentrations are determined by comparison with a known glycogen standard. The kit has a detection sensitivity limit of 120 nM glycogen.
NCBI and Uniprot Product Information
Uniprot Description
Transfers the glycosyl residue from UDP-Glc to the non-reducing end of alpha-1,4-glucan.
Similar Products
Product Notes
The Glycogen abl_01913 (Catalog #AAA169279) is an Assay Kit and is intended for research purposes only. The product is available for immediate purchase. It is sometimes possible for the material contained within the vial of "Glycogen, Assay Kit" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.